Hydralazine

Hydralazine

SCHEMBL3995896

NNc1nncc2ccccc12.NNc1nncc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
NPC1 O15118 4/20 1.00
RAB9A P51151 4/20 1.00
GOT1 P17174 3/20 1.00
LMNA P02545 3/20 1.00
KDM4E B2RXH2 2/20 1.00
TP53 P04637 2/20 1.00
CYP3A4 P08684 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
MAOA P21397 2/20 1.00
PTGS1 P23219 2/20 1.00
MPO P05164 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP2D6 P10635 2/20 1.00
PKM P14618 1/20 1.00
THPO P40225 1/20 1.00
AOX1 Q06278 1/20 1.00
ACOX1 Q15067 1/20 1.00
MAPT P10636 3/20 0.96
TDP1 Q9NUW8 2/20 0.96

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydralazine SCHEMBL7810 1.00 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL36271 0.98 GOT1 (1.00) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL27864907 0.98 GOT1 (1.00) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL1173534 0.98 GOT1 (1.00) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL1650561 0.96 ALDH1A1 (0.93) ALDH1A1NPC1RAB9AGOT1LMNA
Dihydralazine SCHEMBL13724517 0.96 ALDH1A1 (0.93) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL2780318 0.94 ALDH1A1 (0.89) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL2781885 0.90 NPC1 (0.81) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL8703662 0.90 ALDH1A1 (0.81) ALDH1A1NPC1RAB9AGOT1LMNA
Hydralazine SCHEMBL2779460 0.90 NPC1 (0.81) ALDH1A1NPC1RAB9AGOT1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2063875-A2 COMBINATION PHARMACEUTICAL COMPOSITIONS Sigmoid Pharma Limited (IE) 2009-06-03 EP disclosed
WO-2008132712-A2 COMBINATION PHARMACEUTICAL COMPOSITIONS SIGMOID PHARMA LIMITED (IE) 2008-11-06 WO disclosed